Preferred Name |
temsirolimus |
Synonyms |
rapamycin 42-(2,2-bis(hydroxymethyl)propionate) |
ID |
http://purl.bioontology.org/ontology/MESH/C401859 |
altLabel |
rapamycin 42-(2,2-bis(hydroxymethyl)propionate) Torisel CCI 779 CCI-779 rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate) |
cui |
C0796512 C1707080 C1951646 |
Has mapping qualifier | |
HM |
D020123/Q000031 |
II |
D047428 D000970 |
Inverse of RB |
0 624KN6GM2T |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19991217 |
MeSH Frequency |
884 |
MMR |
20210701 |
notation |
C401859 |
PA |
D000091203 |
prefLabel |
temsirolimus |
SC |
1 |
Scope Statement |
structure in first source; inhibits mTOR protein |
SRC |
Bull Cancer 1999 Oct;86(10):808-11 |
TERMUI |
T403101 T403100 T675184 T707936 T000913136 |
TH |
NLM (2006) FDA SRS (2015) NLM (2017) FDA SRS (2017) USAN (19XX) NLM (2007) NLM (1999) INN (19XX) |
tui |
T109 T121 |